SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NPSP NPS Pharmaceutical
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
363 40 0 NPSP
Emcee:  Jim Langdon Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
163ML raises target to $46 from $37. Message 19314593Icebrg-9/17/2003
162NPS Pharmaceuticals (NPSP-NASDAQ) by JMP Securities (32.30, Sept. 9) Amgen annomopgcw-9/16/2003
161NPS Pharmaceuticals Announces NDA Filing by Amgen for Cinacalcet HCL Monday Septscaram(o)uche-9/9/2003
160Molecule of the Month Cinacalcet hydrochloride (AMG-073) is a calcimimetic ageIcebrg-8/28/2003
159I've been waiting for the inevitable pull-back to jump back in. My inevitabtom pope-8/21/2003
158GS Analyst Comment: Stock rating: In-Line Coverage view: Neutral Small-Cap Growmopgcw-8/14/2003
157Tom >> Merrill on NPSP>> Thanks, reminded me that I should try toIcebrg-8/14/2003
156Merrill on NPSP Message 19208655tom pope-8/14/2003
155So when are they going to do their floorless convertible?jayhawk969-6/16/2003
154snip from GS conference presentation report: NPS Pharmaceuticals, Inc. (NPSP) Smopgcw-6/12/2003
153GS Take: Stock rating: In-Line Coverage view: Neutral Small-Cap Growth Price: Umopgcw-5/23/2003
152From ML <i>NPS Pharmaceuticals Inc (NPSP; $17.36; C-1-9) The Catch-22 Thatom pope-3/3/2003
151>>SALT LAKE CITY, Feb. 26 /PRNewswire-FirstCall/ -- NPS Pharmaceuticals, Ituck-2/26/2003
150NPS Pharmaceuticals to Report Fourth Quarter and Year-End Operating Results MonSemiBull-2/24/2003
149Merrill Lynch is still interested, certainly gives me something to chew on overntom pope-2/20/2003
148If anyone is left on this thread...... NPS, Seeking Cash, is Acquiring Enzon TSemiBull-2/20/2003
147Press Release Source: Amgen First-In-Class Oral Calcimimetic Shown To Reduce PMiljenko Zuanic-11/3/2002
146>>WASHINGTON -(Dow Jones)- NPS Pharmaceuticals Inc. (NasdaqNM:NPSP - News)tuck-10/21/2002
145SALT LAKE CITY, Oct. 18 /PRNewswire-FirstCall/ -- NPS Pharmaceuticals, Inc. (Nasnigel bates-10/18/2002
144Might be of interest here. fda.govkeokalani'nui-9/4/2002
143NPS Reports Interim PREOS Carcinogenicity Results SALT LAKE CITY, Aug. 15 /PRNeSemiBull-8/15/2002
142Briefing.com has a positive note on NPSP: [July 25, 2002] 15:04 ET NPS PharmaDoc Bones-7/26/2002
141NPS Pharmaceuticals Reports Successful Production of PREOS, Second Quarter 2002 SemiBull-7/23/2002
140NPS Pharmaceuticals Announces Appointment of Gerard Michel as Vice President, CoSemiBull-7/4/2002
139NPS Update on Preos Manufacturing SALT LAKE CITY, June 11 /PRNewswire-FirstCallSemiBull-6/11/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News